BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30606923)

  • 1. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
    Kitao T; Ito Y; Fukui M; Yamamoto M; Shoji Y; Takeda S; Shirahase H
    Yakugaku Zasshi; 2019; 139(1):19-25. PubMed ID: 30606923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic Effects of KY-054, a Novel Coumarin Derivative on Femur Cortical Bone in Ovariectomized Female Rats.
    Yamamoto M; Ito Y; Fukui M; Otake K; Shoji Y; Kitao T; Shirahase H; Hinoi E
    Biol Pharm Bull; 2023; 46(10):1435-1443. PubMed ID: 37779045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats.
    Yamamoto M; Shibata Y; Ito Y; Fukui M; Kioka H; Shoji Y; Kitao T; Shirahase H; Hinoi E
    Biol Pharm Bull; 2024; 47(3):669-679. PubMed ID: 38508765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model.
    Zhang F; Xie J; Wang G; Zhang G; Yang H
    J Cell Physiol; 2018 Jun; 233(6):4626-4633. PubMed ID: 28926099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.
    Lee CG; Kim J; Yun SH; Hwang S; Jeon H; Park E; Jeong SY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.
    Zhou RP; Lin SJ; Wan WB; Zuo HL; Yao FF; Ruan HB; Xu J; Song W; Zhou YC; Wen SY; Dai JH; Zhu ML; Luo J
    PLoS One; 2016; 11(12):e0166751. PubMed ID: 28033335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor κB ligand in osteoblasts: Negative impact of the drug on peak bone accrual in rats.
    Pal China S; Pal S; Chattopadhyay S; Porwal K; Mittal M; Sanyal S; Chattopadhyay N
    Toxicol Appl Pharmacol; 2018 Jun; 348():22-31. PubMed ID: 29649498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.
    Sims NA; Ng KW
    Curr Osteoporos Rep; 2014 Mar; 12(1):98-106. PubMed ID: 24477416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
    Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
    Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of phosphodiesterase inhibitors in the treatment of osteoporosis: Scopes for therapeutic repurposing and discovery of new oral osteoanabolic drugs.
    Porwal K; Pal S; Bhagwati S; Siddiqi MI; Chattopadhyay N
    Eur J Pharmacol; 2021 May; 899():174015. PubMed ID: 33711307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice.
    Alles N; Soysa NS; Hayashi J; Khan M; Shimoda A; Shimokawa H; Ritzeler O; Akiyoshi K; Aoki K; Ohya K
    Endocrinology; 2010 Oct; 151(10):4626-34. PubMed ID: 20810563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
    Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
    Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiosteoporotic activity of Davallia formosana.
    Ko YJ; Wu JB; Ho HY; Lin WC
    J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro.
    Wu Z; Weng S; Yan D; Xie Z; Zhou Q; Li H; Bai B; Boodhun V; Shen Z; Tang J; Zhou L; Tao Z; Yang L
    J Pharmacol Sci; 2018 Sep; 138(1):63-70. PubMed ID: 30266553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitargeted combination effects of a triherbal formulation containing ELP against osteoporosis: in vitro evidence.
    Ko CH; Lau KM; Chau L; Cheung DW; Siu WS; Wong HL; Shum WT; Gao S; Fung KP; Leung PC; Poon SK; Lau CB
    J Pharm Pharmacol; 2016 Jun; 68(6):826-33. PubMed ID: 27019348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.